nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Tamoxifen—pancreatic cancer	0.159	0.219	CbGbCtD
Perhexiline—CYP2B6—Irinotecan—pancreatic cancer	0.122	0.168	CbGbCtD
Perhexiline—CYP2D6—Tamoxifen—pancreatic cancer	0.0769	0.106	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—pancreatic cancer	0.0668	0.092	CbGbCtD
Perhexiline—CYP2D6—Erlotinib—pancreatic cancer	0.0654	0.09	CbGbCtD
Perhexiline—CYP3A4—Tamoxifen—pancreatic cancer	0.0489	0.0673	CbGbCtD
Perhexiline—CYP3A4—Erlotinib—pancreatic cancer	0.0416	0.0573	CbGbCtD
Perhexiline—CYP3A4—Irinotecan—pancreatic cancer	0.0375	0.0517	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—pancreatic cancer	0.0322	0.0444	CbGbCtD
Perhexiline—Walking disability—Tamoxifen—pancreatic cancer	0.0306	0.114	CcSEcCtD
Perhexiline—CYP3A4—Docetaxel—pancreatic cancer	0.0275	0.0379	CbGbCtD
Perhexiline—CYP3A4—Sunitinib—pancreatic cancer	0.0274	0.0377	CbGbCtD
Perhexiline—CYP3A4—Doxorubicin—pancreatic cancer	0.0205	0.0282	CbGbCtD
Perhexiline—Unsteadiness—Fluorouracil—pancreatic cancer	0.0119	0.0443	CcSEcCtD
Perhexiline—Hypertriglyceridaemia—Tamoxifen—pancreatic cancer	0.00613	0.0229	CcSEcCtD
Perhexiline—Optic neuritis—Tamoxifen—pancreatic cancer	0.00573	0.0214	CcSEcCtD
Perhexiline—Blood triglycerides increased—Tamoxifen—pancreatic cancer	0.00538	0.0201	CcSEcCtD
Perhexiline—Polyneuropathy—Docetaxel—pancreatic cancer	0.00527	0.0197	CcSEcCtD
Perhexiline—Balance disorder—Fluorouracil—pancreatic cancer	0.00435	0.0163	CcSEcCtD
Perhexiline—Torsade de pointes—Sunitinib—pancreatic cancer	0.0043	0.0161	CcSEcCtD
Perhexiline—Liver injury—Tamoxifen—pancreatic cancer	0.00419	0.0156	CcSEcCtD
Perhexiline—Cachexia—Epirubicin—pancreatic cancer	0.00405	0.0152	CcSEcCtD
Perhexiline—Cachexia—Doxorubicin—pancreatic cancer	0.00375	0.014	CcSEcCtD
Perhexiline—Gait disturbance—Tamoxifen—pancreatic cancer	0.00361	0.0135	CcSEcCtD
Perhexiline—Polyneuropathy—Epirubicin—pancreatic cancer	0.00355	0.0133	CcSEcCtD
Perhexiline—Hepatocellular injury—Tamoxifen—pancreatic cancer	0.00352	0.0132	CcSEcCtD
Perhexiline—Hepatocellular injury—Erlotinib—pancreatic cancer	0.00348	0.013	CcSEcCtD
Perhexiline—Polyneuropathy—Doxorubicin—pancreatic cancer	0.00329	0.0123	CcSEcCtD
Perhexiline—Gait disturbance—Irinotecan—pancreatic cancer	0.00255	0.00952	CcSEcCtD
Perhexiline—Hypoglycaemia—Sunitinib—pancreatic cancer	0.00224	0.00839	CcSEcCtD
Perhexiline—Weight decreased—Tamoxifen—pancreatic cancer	0.002	0.00747	CcSEcCtD
Perhexiline—Weight decreased—Erlotinib—pancreatic cancer	0.00198	0.0074	CcSEcCtD
Perhexiline—Muscular weakness—Sunitinib—pancreatic cancer	0.00193	0.00722	CcSEcCtD
Perhexiline—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00191	0.00714	CcSEcCtD
Perhexiline—Sweating—Tamoxifen—pancreatic cancer	0.00189	0.00706	CcSEcCtD
Perhexiline—Optic neuritis—Epirubicin—pancreatic cancer	0.00188	0.00704	CcSEcCtD
Perhexiline—Hepatitis—Tamoxifen—pancreatic cancer	0.00177	0.00661	CcSEcCtD
Perhexiline—Hepatitis—Erlotinib—pancreatic cancer	0.00175	0.00654	CcSEcCtD
Perhexiline—Optic neuritis—Doxorubicin—pancreatic cancer	0.00174	0.00652	CcSEcCtD
Perhexiline—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00172	0.00642	CcSEcCtD
Perhexiline—Weight decreased—Sunitinib—pancreatic cancer	0.00171	0.0064	CcSEcCtD
Perhexiline—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00165	0.00618	CcSEcCtD
Perhexiline—Flushing—Tamoxifen—pancreatic cancer	0.00164	0.00614	CcSEcCtD
Perhexiline—Ataxia—Fluorouracil—pancreatic cancer	0.00162	0.00607	CcSEcCtD
Perhexiline—Muscular weakness—Fluorouracil—pancreatic cancer	0.00152	0.0057	CcSEcCtD
Perhexiline—Hepatitis—Sunitinib—pancreatic cancer	0.00151	0.00566	CcSEcCtD
Perhexiline—Weight decreased—Irinotecan—pancreatic cancer	0.00141	0.00527	CcSEcCtD
Perhexiline—Flushing—Sunitinib—pancreatic cancer	0.00141	0.00526	CcSEcCtD
Perhexiline—Liver injury—Epirubicin—pancreatic cancer	0.00138	0.00515	CcSEcCtD
Perhexiline—Syncope—Erlotinib—pancreatic cancer	0.00137	0.00511	CcSEcCtD
Perhexiline—Loss of consciousness—Erlotinib—pancreatic cancer	0.00134	0.00501	CcSEcCtD
Perhexiline—Sweating—Irinotecan—pancreatic cancer	0.00133	0.00498	CcSEcCtD
Perhexiline—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00133	0.00496	CcSEcCtD
Perhexiline—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.0013	0.00488	CcSEcCtD
Perhexiline—Sweating—Gemcitabine—pancreatic cancer	0.0013	0.00485	CcSEcCtD
Perhexiline—Liver injury—Doxorubicin—pancreatic cancer	0.00127	0.00476	CcSEcCtD
Perhexiline—Shock—Erlotinib—pancreatic cancer	0.00122	0.00457	CcSEcCtD
Perhexiline—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00121	0.00454	CcSEcCtD
Perhexiline—Anorexia—Tamoxifen—pancreatic cancer	0.0012	0.00448	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—pancreatic cancer	0.00119	0.00444	CcSEcCtD
Perhexiline—Anorexia—Erlotinib—pancreatic cancer	0.00119	0.00443	CcSEcCtD
Perhexiline—Ataxia—Docetaxel—pancreatic cancer	0.00117	0.00438	CcSEcCtD
Perhexiline—Hepatocellular injury—Epirubicin—pancreatic cancer	0.00116	0.00433	CcSEcCtD
Perhexiline—Flushing—Irinotecan—pancreatic cancer	0.00116	0.00433	CcSEcCtD
Perhexiline—Convulsion—Sunitinib—pancreatic cancer	0.00114	0.00427	CcSEcCtD
Perhexiline—Insomnia—Tamoxifen—pancreatic cancer	0.00114	0.00425	CcSEcCtD
Perhexiline—Paraesthesia—Tamoxifen—pancreatic cancer	0.00113	0.00422	CcSEcCtD
Perhexiline—Insomnia—Erlotinib—pancreatic cancer	0.00112	0.0042	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—pancreatic cancer	0.0011	0.00411	CcSEcCtD
Perhexiline—Decreased appetite—Tamoxifen—pancreatic cancer	0.00109	0.00408	CcSEcCtD
Perhexiline—Fatigue—Tamoxifen—pancreatic cancer	0.00108	0.00405	CcSEcCtD
Perhexiline—Decreased appetite—Erlotinib—pancreatic cancer	0.00108	0.00404	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.00107	0.00401	CcSEcCtD
Perhexiline—Fatigue—Erlotinib—pancreatic cancer	0.00107	0.00401	CcSEcCtD
Perhexiline—Shock—Sunitinib—pancreatic cancer	0.00106	0.00396	CcSEcCtD
Perhexiline—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00103	0.00384	CcSEcCtD
Perhexiline—Anorexia—Sunitinib—pancreatic cancer	0.00103	0.00384	CcSEcCtD
Perhexiline—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00102	0.0038	CcSEcCtD
Perhexiline—Urticaria—Tamoxifen—pancreatic cancer	0.000998	0.00373	CcSEcCtD
Perhexiline—Abdominal pain—Tamoxifen—pancreatic cancer	0.000993	0.00371	CcSEcCtD
Perhexiline—Abdominal pain—Erlotinib—pancreatic cancer	0.000983	0.00367	CcSEcCtD
Perhexiline—Weight decreased—Docetaxel—pancreatic cancer	0.000975	0.00365	CcSEcCtD
Perhexiline—Syncope—Irinotecan—pancreatic cancer	0.000974	0.00364	CcSEcCtD
Perhexiline—Insomnia—Sunitinib—pancreatic cancer	0.000973	0.00364	CcSEcCtD
Perhexiline—Paraesthesia—Sunitinib—pancreatic cancer	0.000966	0.00361	CcSEcCtD
Perhexiline—Loss of consciousness—Irinotecan—pancreatic cancer	0.000955	0.00357	CcSEcCtD
Perhexiline—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000942	0.00352	CcSEcCtD
Perhexiline—Decreased appetite—Sunitinib—pancreatic cancer	0.000936	0.0035	CcSEcCtD
Perhexiline—Fatigue—Sunitinib—pancreatic cancer	0.000928	0.00347	CcSEcCtD
Perhexiline—Asthenia—Tamoxifen—pancreatic cancer	0.000902	0.00337	CcSEcCtD
Perhexiline—Convulsion—Fluorouracil—pancreatic cancer	0.000901	0.00337	CcSEcCtD
Perhexiline—Asthenia—Erlotinib—pancreatic cancer	0.000892	0.00334	CcSEcCtD
Perhexiline—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00088	0.00329	CcSEcCtD
Perhexiline—Shock—Irinotecan—pancreatic cancer	0.000872	0.00326	CcSEcCtD
Perhexiline—Hepatitis—Docetaxel—pancreatic cancer	0.000863	0.00323	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000862	0.00322	CcSEcCtD
Perhexiline—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000857	0.0032	CcSEcCtD
Perhexiline—Abdominal pain—Sunitinib—pancreatic cancer	0.000851	0.00318	CcSEcCtD
Perhexiline—Anorexia—Irinotecan—pancreatic cancer	0.000845	0.00316	CcSEcCtD
Perhexiline—Diplopia—Epirubicin—pancreatic cancer	0.000841	0.00314	CcSEcCtD
Perhexiline—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000835	0.00312	CcSEcCtD
Perhexiline—Dizziness—Tamoxifen—pancreatic cancer	0.000831	0.00311	CcSEcCtD
Perhexiline—Anorexia—Gemcitabine—pancreatic cancer	0.000823	0.00308	CcSEcCtD
Perhexiline—Dizziness—Erlotinib—pancreatic cancer	0.000822	0.00307	CcSEcCtD
Perhexiline—Anorexia—Fluorouracil—pancreatic cancer	0.000809	0.00303	CcSEcCtD
Perhexiline—Insomnia—Irinotecan—pancreatic cancer	0.000802	0.003	CcSEcCtD
Perhexiline—Flushing—Docetaxel—pancreatic cancer	0.000801	0.00299	CcSEcCtD
Perhexiline—Vomiting—Tamoxifen—pancreatic cancer	0.000799	0.00299	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000797	0.00298	CcSEcCtD
Perhexiline—Paraesthesia—Irinotecan—pancreatic cancer	0.000796	0.00298	CcSEcCtD
Perhexiline—Rash—Tamoxifen—pancreatic cancer	0.000792	0.00296	CcSEcCtD
Perhexiline—Dermatitis—Tamoxifen—pancreatic cancer	0.000792	0.00296	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—pancreatic cancer	0.000791	0.00296	CcSEcCtD
Perhexiline—Vomiting—Erlotinib—pancreatic cancer	0.00079	0.00296	CcSEcCtD
Perhexiline—Headache—Tamoxifen—pancreatic cancer	0.000787	0.00294	CcSEcCtD
Perhexiline—Rash—Erlotinib—pancreatic cancer	0.000784	0.00293	CcSEcCtD
Perhexiline—Dermatitis—Erlotinib—pancreatic cancer	0.000783	0.00293	CcSEcCtD
Perhexiline—Insomnia—Gemcitabine—pancreatic cancer	0.000781	0.00292	CcSEcCtD
Perhexiline—Headache—Erlotinib—pancreatic cancer	0.000779	0.00291	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—pancreatic cancer	0.000778	0.00291	CcSEcCtD
Perhexiline—Paraesthesia—Gemcitabine—pancreatic cancer	0.000775	0.0029	CcSEcCtD
Perhexiline—Asthenia—Sunitinib—pancreatic cancer	0.000772	0.00289	CcSEcCtD
Perhexiline—Decreased appetite—Irinotecan—pancreatic cancer	0.000771	0.00288	CcSEcCtD
Perhexiline—Insomnia—Fluorouracil—pancreatic cancer	0.000768	0.00287	CcSEcCtD
Perhexiline—Fatigue—Irinotecan—pancreatic cancer	0.000764	0.00286	CcSEcCtD
Perhexiline—Paraesthesia—Fluorouracil—pancreatic cancer	0.000762	0.00285	CcSEcCtD
Perhexiline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000751	0.00281	CcSEcCtD
Perhexiline—Nausea—Tamoxifen—pancreatic cancer	0.000746	0.00279	CcSEcCtD
Perhexiline—Fatigue—Gemcitabine—pancreatic cancer	0.000745	0.00278	CcSEcCtD
Perhexiline—Muscular weakness—Epirubicin—pancreatic cancer	0.000742	0.00277	CcSEcCtD
Perhexiline—Nausea—Erlotinib—pancreatic cancer	0.000738	0.00276	CcSEcCtD
Perhexiline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000738	0.00276	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—pancreatic cancer	0.000732	0.00274	CcSEcCtD
Perhexiline—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000725	0.00271	CcSEcCtD
Perhexiline—Dizziness—Sunitinib—pancreatic cancer	0.000712	0.00266	CcSEcCtD
Perhexiline—Abdominal pain—Irinotecan—pancreatic cancer	0.000701	0.00262	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—pancreatic cancer	0.000686	0.00257	CcSEcCtD
Perhexiline—Vomiting—Sunitinib—pancreatic cancer	0.000684	0.00256	CcSEcCtD
Perhexiline—Rash—Sunitinib—pancreatic cancer	0.000679	0.00254	CcSEcCtD
Perhexiline—Dermatitis—Sunitinib—pancreatic cancer	0.000678	0.00253	CcSEcCtD
Perhexiline—Urticaria—Fluorouracil—pancreatic cancer	0.000675	0.00252	CcSEcCtD
Perhexiline—Headache—Sunitinib—pancreatic cancer	0.000674	0.00252	CcSEcCtD
Perhexiline—Syncope—Docetaxel—pancreatic cancer	0.000673	0.00252	CcSEcCtD
Perhexiline—Loss of consciousness—Docetaxel—pancreatic cancer	0.00066	0.00247	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.000658	0.1	CbGpPWpGaD
Perhexiline—Weight decreased—Epirubicin—pancreatic cancer	0.000658	0.00246	CcSEcCtD
Perhexiline—Convulsion—Docetaxel—pancreatic cancer	0.000651	0.00243	CcSEcCtD
Perhexiline—Nausea—Sunitinib—pancreatic cancer	0.000639	0.00239	CcSEcCtD
Perhexiline—Asthenia—Irinotecan—pancreatic cancer	0.000636	0.00238	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000635	0.00238	CcSEcCtD
Perhexiline—Sweating—Epirubicin—pancreatic cancer	0.000621	0.00232	CcSEcCtD
Perhexiline—Asthenia—Gemcitabine—pancreatic cancer	0.00062	0.00232	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—pancreatic cancer	0.000608	0.00228	CcSEcCtD
Perhexiline—Shock—Docetaxel—pancreatic cancer	0.000603	0.00225	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000588	0.0022	CcSEcCtD
Perhexiline—Dizziness—Irinotecan—pancreatic cancer	0.000586	0.00219	CcSEcCtD
Perhexiline—Anorexia—Docetaxel—pancreatic cancer	0.000584	0.00218	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—pancreatic cancer	0.000582	0.00218	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—pancreatic cancer	0.000575	0.00215	CcSEcCtD
Perhexiline—Vomiting—Irinotecan—pancreatic cancer	0.000564	0.00211	CcSEcCtD
Perhexiline—Dizziness—Fluorouracil—pancreatic cancer	0.000561	0.0021	CcSEcCtD
Perhexiline—Rash—Irinotecan—pancreatic cancer	0.000559	0.00209	CcSEcCtD
Perhexiline—Dermatitis—Irinotecan—pancreatic cancer	0.000558	0.00209	CcSEcCtD
Perhexiline—Headache—Irinotecan—pancreatic cancer	0.000555	0.00208	CcSEcCtD
Perhexiline—Insomnia—Docetaxel—pancreatic cancer	0.000554	0.00207	CcSEcCtD
Perhexiline—Paraesthesia—Docetaxel—pancreatic cancer	0.00055	0.00206	CcSEcCtD
Perhexiline—Vomiting—Gemcitabine—pancreatic cancer	0.000549	0.00205	CcSEcCtD
Perhexiline—Rash—Gemcitabine—pancreatic cancer	0.000544	0.00204	CcSEcCtD
Perhexiline—Dermatitis—Gemcitabine—pancreatic cancer	0.000544	0.00203	CcSEcCtD
Perhexiline—Headache—Gemcitabine—pancreatic cancer	0.000541	0.00202	CcSEcCtD
Perhexiline—Flushing—Epirubicin—pancreatic cancer	0.00054	0.00202	CcSEcCtD
Perhexiline—Vomiting—Fluorouracil—pancreatic cancer	0.00054	0.00202	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—pancreatic cancer	0.000538	0.00201	CcSEcCtD
Perhexiline—Rash—Fluorouracil—pancreatic cancer	0.000535	0.002	CcSEcCtD
Perhexiline—Dermatitis—Fluorouracil—pancreatic cancer	0.000535	0.002	CcSEcCtD
Perhexiline—Decreased appetite—Docetaxel—pancreatic cancer	0.000533	0.00199	CcSEcCtD
Perhexiline—Headache—Fluorouracil—pancreatic cancer	0.000532	0.00199	CcSEcCtD
Perhexiline—Fatigue—Docetaxel—pancreatic cancer	0.000528	0.00198	CcSEcCtD
Perhexiline—Nausea—Irinotecan—pancreatic cancer	0.000527	0.00197	CcSEcCtD
Perhexiline—Nausea—Gemcitabine—pancreatic cancer	0.000513	0.00192	CcSEcCtD
Perhexiline—Nausea—Fluorouracil—pancreatic cancer	0.000504	0.00189	CcSEcCtD
Perhexiline—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000501	0.00187	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—pancreatic cancer	0.0005	0.00187	CcSEcCtD
Perhexiline—Tension—Epirubicin—pancreatic cancer	0.000497	0.00186	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—pancreatic cancer	0.000492	0.00184	CcSEcCtD
Perhexiline—Abdominal pain—Docetaxel—pancreatic cancer	0.000484	0.00181	CcSEcCtD
Perhexiline—Tension—Doxorubicin—pancreatic cancer	0.00046	0.00172	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—pancreatic cancer	0.000455	0.0017	CcSEcCtD
Perhexiline—Syncope—Epirubicin—pancreatic cancer	0.000454	0.0017	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—pancreatic cancer	0.000445	0.00166	CcSEcCtD
Perhexiline—Asthenia—Docetaxel—pancreatic cancer	0.00044	0.00164	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—pancreatic cancer	0.000439	0.00164	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—pancreatic cancer	0.00042	0.00157	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.000415	0.0631	CbGpPWpGaD
Perhexiline—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000412	0.00154	CcSEcCtD
Perhexiline—Shock—Epirubicin—pancreatic cancer	0.000407	0.00152	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—pancreatic cancer	0.000406	0.00152	CcSEcCtD
Perhexiline—Dizziness—Docetaxel—pancreatic cancer	0.000405	0.00152	CcSEcCtD
Perhexiline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.0004	0.00149	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—pancreatic cancer	0.000394	0.00147	CcSEcCtD
Perhexiline—Vomiting—Docetaxel—pancreatic cancer	0.00039	0.00146	CcSEcCtD
Perhexiline—Rash—Docetaxel—pancreatic cancer	0.000386	0.00144	CcSEcCtD
Perhexiline—Dermatitis—Docetaxel—pancreatic cancer	0.000386	0.00144	CcSEcCtD
Perhexiline—Headache—Docetaxel—pancreatic cancer	0.000384	0.00144	CcSEcCtD
Perhexiline—Shock—Doxorubicin—pancreatic cancer	0.000376	0.00141	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—pancreatic cancer	0.000374	0.0014	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—pancreatic cancer	0.000371	0.00139	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00037	0.00138	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—pancreatic cancer	0.000365	0.00136	CcSEcCtD
Perhexiline—Nausea—Docetaxel—pancreatic cancer	0.000364	0.00136	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—pancreatic cancer	0.000359	0.00134	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—pancreatic cancer	0.000356	0.00133	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—pancreatic cancer	0.000346	0.00129	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—pancreatic cancer	0.000343	0.00128	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000338	0.00126	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—pancreatic cancer	0.000332	0.00124	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—pancreatic cancer	0.00033	0.00123	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—pancreatic cancer	0.000328	0.00123	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—pancreatic cancer	0.000327	0.00122	CcSEcCtD
Perhexiline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000313	0.00117	CcSEcCtD
Perhexiline—Urticaria—Doxorubicin—pancreatic cancer	0.000304	0.00114	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—pancreatic cancer	0.000302	0.00113	CcSEcCtD
Perhexiline—Asthenia—Epirubicin—pancreatic cancer	0.000297	0.00111	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—CCND1—pancreatic cancer	0.000276	0.042	CbGpPWpGaD
Perhexiline—Asthenia—Doxorubicin—pancreatic cancer	0.000274	0.00103	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—pancreatic cancer	0.000273	0.00102	CcSEcCtD
Perhexiline—Vomiting—Epirubicin—pancreatic cancer	0.000263	0.000983	CcSEcCtD
Perhexiline—Rash—Epirubicin—pancreatic cancer	0.000261	0.000974	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—pancreatic cancer	0.00026	0.000974	CcSEcCtD
Perhexiline—Headache—Epirubicin—pancreatic cancer	0.000259	0.000968	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—pancreatic cancer	0.000253	0.000946	CcSEcCtD
Perhexiline—Nausea—Epirubicin—pancreatic cancer	0.000246	0.000918	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—pancreatic cancer	0.000243	0.000909	CcSEcCtD
Perhexiline—Rash—Doxorubicin—pancreatic cancer	0.000241	0.000902	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—pancreatic cancer	0.000241	0.000901	CcSEcCtD
Perhexiline—Headache—Doxorubicin—pancreatic cancer	0.00024	0.000896	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000229	0.0349	CbGpPWpGaD
Perhexiline—Nausea—Doxorubicin—pancreatic cancer	0.000227	0.000849	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—pancreatic cancer	0.000221	0.0337	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00022	0.0336	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—STK11—pancreatic cancer	0.000202	0.0308	CbGpPWpGaD
Perhexiline—CPT1A—PPAR Alpha Pathway—CCND1—pancreatic cancer	0.000191	0.0291	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000174	0.0264	CbGpPWpGaD
Perhexiline—CPT1A—Circadian Clock—HIF1A—pancreatic cancer	0.000174	0.0264	CbGpPWpGaD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—pancreatic cancer	0.000153	0.0233	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TSC2—pancreatic cancer	0.000144	0.022	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—AHR—pancreatic cancer	0.000135	0.0206	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CG—pancreatic cancer	0.000128	0.0194	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000125	0.0191	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—PPARG—pancreatic cancer	0.000122	0.0186	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	0.00012	0.0182	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CD—pancreatic cancer	0.000112	0.0171	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—EZH2—pancreatic cancer	0.000102	0.0155	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CB—pancreatic cancer	9.77e-05	0.0149	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HES1—pancreatic cancer	8.99e-05	0.0137	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—PPARG—pancreatic cancer	8.48e-05	0.0129	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	8.29e-05	0.0126	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	8.25e-05	0.0126	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	7.54e-05	0.0115	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TYMS—pancreatic cancer	7.39e-05	0.0112	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	6.97e-05	0.0106	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PRSS1—pancreatic cancer	6.03e-05	0.00918	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—pancreatic cancer	5.96e-05	0.00907	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—pancreatic cancer	5.76e-05	0.00877	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	5.72e-05	0.0087	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PPARG—pancreatic cancer	5.23e-05	0.00797	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ARG2—pancreatic cancer	5.23e-05	0.00796	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.13e-05	0.00781	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.89e-05	0.00745	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—pancreatic cancer	4.87e-05	0.00741	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.68e-05	0.00713	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	4.65e-05	0.00708	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TYMP—pancreatic cancer	4.57e-05	0.00696	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.51e-05	0.00687	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PRSS1—pancreatic cancer	4.18e-05	0.00636	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	3.97e-05	0.00605	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.77e-05	0.00574	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GLP1R—pancreatic cancer	3.68e-05	0.00561	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ARG2—pancreatic cancer	3.62e-05	0.00552	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—DPYD—pancreatic cancer	3.62e-05	0.00552	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—pancreatic cancer	3.59e-05	0.00547	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC2A2—pancreatic cancer	3.44e-05	0.00523	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.4e-05	0.00518	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.4e-05	0.00518	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.28e-05	0.005	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMP—pancreatic cancer	3.17e-05	0.00482	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.99e-05	0.00455	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CD44—pancreatic cancer	2.66e-05	0.00405	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.61e-05	0.00398	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.61e-05	0.00397	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.58e-05	0.00393	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GCG—pancreatic cancer	2.55e-05	0.00389	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GLP1R—pancreatic cancer	2.55e-05	0.00389	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—DPYD—pancreatic cancer	2.51e-05	0.00382	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—pancreatic cancer	2.45e-05	0.00373	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—STK11—pancreatic cancer	2.4e-05	0.00365	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC2A2—pancreatic cancer	2.38e-05	0.00363	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.36e-05	0.00359	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.33e-05	0.00355	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.28e-05	0.00347	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.25e-05	0.00343	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.07e-05	0.00316	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TYMS—pancreatic cancer	2.06e-05	0.00314	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CD44—pancreatic cancer	1.85e-05	0.00281	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.81e-05	0.00275	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.79e-05	0.00273	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GCG—pancreatic cancer	1.77e-05	0.00269	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—APOE—pancreatic cancer	1.68e-05	0.00256	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—STK11—pancreatic cancer	1.66e-05	0.00253	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.59e-05	0.00242	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.56e-05	0.00238	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CG—pancreatic cancer	1.52e-05	0.00231	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPARG—pancreatic cancer	1.46e-05	0.00223	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMS—pancreatic cancer	1.43e-05	0.00218	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CD—pancreatic cancer	1.33e-05	0.00203	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—APOE—pancreatic cancer	1.16e-05	0.00177	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CB—pancreatic cancer	1.16e-05	0.00177	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—pancreatic cancer	1.15e-05	0.00175	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.1e-05	0.00168	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CG—pancreatic cancer	1.05e-05	0.0016	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPARG—pancreatic cancer	1.01e-05	0.00154	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—pancreatic cancer	1e-05	0.00153	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PRSS1—pancreatic cancer	9.89e-06	0.00151	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CD—pancreatic cancer	9.23e-06	0.00141	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ARG2—pancreatic cancer	8.57e-06	0.00131	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CB—pancreatic cancer	8.05e-06	0.00123	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—pancreatic cancer	7.97e-06	0.00121	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMP—pancreatic cancer	7.49e-06	0.00114	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—pancreatic cancer	7.08e-06	0.00108	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—pancreatic cancer	6.95e-06	0.00106	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PRSS1—pancreatic cancer	6.87e-06	0.00105	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GLP1R—pancreatic cancer	6.04e-06	0.00092	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ARG2—pancreatic cancer	5.96e-06	0.000907	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—DPYD—pancreatic cancer	5.94e-06	0.000905	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—pancreatic cancer	5.78e-06	0.00088	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	5.64e-06	0.000859	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMP—pancreatic cancer	5.21e-06	0.000793	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—pancreatic cancer	4.91e-06	0.000747	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.49e-06	0.000684	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CD44—pancreatic cancer	4.37e-06	0.000665	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GLP1R—pancreatic cancer	4.2e-06	0.000639	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GCG—pancreatic cancer	4.19e-06	0.000637	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—DPYD—pancreatic cancer	4.13e-06	0.000629	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—pancreatic cancer	4.01e-06	0.00061	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—STK11—pancreatic cancer	3.94e-06	0.000599	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	3.92e-06	0.000597	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.9e-06	0.000593	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.4e-06	0.000518	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMS—pancreatic cancer	3.39e-06	0.000516	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CD44—pancreatic cancer	3.04e-06	0.000462	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GCG—pancreatic cancer	2.91e-06	0.000443	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APOE—pancreatic cancer	2.75e-06	0.000419	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.74e-06	0.000418	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—STK11—pancreatic cancer	2.74e-06	0.000417	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.7e-06	0.000411	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.56e-06	0.00039	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	2.49e-06	0.000378	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARG—pancreatic cancer	2.4e-06	0.000365	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.35e-06	0.000358	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	0.000333	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CD44—pancreatic cancer	1.98e-06	0.000302	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APOE—pancreatic cancer	1.91e-06	0.000291	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	0.00029	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GCG—pancreatic cancer	1.9e-06	0.00029	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—pancreatic cancer	1.89e-06	0.000287	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—STK11—pancreatic cancer	1.79e-06	0.000272	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.73e-06	0.000263	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.67e-06	0.000254	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.65e-06	0.000251	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.54e-06	0.000234	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.52e-06	0.000231	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.32e-06	0.000202	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.31e-06	0.0002	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APOE—pancreatic cancer	1.25e-06	0.000191	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	0.000177	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.14e-06	0.000174	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.13e-06	0.000172	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.09e-06	0.000166	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	9.93e-07	0.000151	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—pancreatic cancer	9.48e-07	0.000144	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.65e-07	0.000132	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.57e-07	0.000131	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	8.07e-07	0.000123	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.48e-07	0.000114	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—pancreatic cancer	6.59e-07	0.0001	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.28e-07	8.03e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.31e-07	6.56e-05	CbGpPWpGaD
